Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/1997
10/09/1997CA2249599A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249559A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249369A1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/09/1997CA2249206A1 Apo-2li and apo-3 apoptosis polypeptides
10/09/1997CA2248856A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins
10/09/1997CA2222596A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/08/1997EP0799835A2 Anti-fibroblast growth factor-8 monoclonal antibody
10/08/1997EP0799618A2 Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer
10/08/1997EP0799316A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups
10/08/1997EP0799315A2 Telomerase protein component
10/08/1997EP0799311A1 Human chemokine beta-9
10/08/1997EP0799241A1 Peptides having immunomodulatory activity
10/08/1997EP0799210A1 Piperazine-2,5-dione derivatives as modulators of multidrug resistance
10/08/1997EP0799198A1 Anti-inflammatory compounds
10/08/1997EP0799046A1 Stable solutions of 2-chloro-2'-deoxyadenosine
10/08/1997EP0799038A1 NEW USES OF INDOLO- 2,3b]-QUINOXALINES
10/08/1997EP0686159B1 Farnesyl:protein transferase inhibitors as anticancer agents
10/08/1997EP0595888B1 A process for the preparation of demethylepypodophyllotoxin
10/08/1997EP0584222B1 Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
10/08/1997EP0559838B1 Ecteinascidins 736 and 722
10/08/1997EP0506892B1 Boronated nucleosides
10/08/1997CN1161698A Cyclic hexapeptide somatostatin analogues
10/08/1997CN1161697A Beta, beta'-dihydroxy meso-substituted chlorin, bacteriochlorin, isobacteriochlorin and method for making same
10/08/1997CN1161652A Pharmaceutical compositions
10/08/1997CN1161337A Water soluble rapamycin esters
10/08/1997CN1161330A Substd. quinazoline derivatives
10/07/1997US5675024 Retinoid receptor agonists
10/07/1997US5674994 Polynucleotides encoding the anti-PEM antibody BW835 variable domains and expression vectors
10/07/1997US5674892 Contacting with benzoxacyclotetradecin derivatives
10/07/1997US5674886 Triazolylated teritiary amine compound or salt thereof
10/07/1997US5674874 Anticancer agent
10/07/1997US5674873 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
10/07/1997US5674862 Methods of treating diabetic mellitus and its complications
10/07/1997US5674852 Water-soluble retinoids
10/07/1997US5674749 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-A, and uses thereof
10/07/1997US5674748 Human cyclin-dependent kinase-like proteins and methods of using the same
10/07/1997US5674691 Method of screening for ligands to a receptor-type tyrosine kinase
10/07/1997US5674494 Treating non-malignant disease states with IL-2 receptor-specific substances
10/07/1997US5674492 Method of preventing or treating disease characterized by neoplastic cells expressing CD40
10/07/1997US5674467 Used in nmr diagnosis, radiodiagnosis or radiotherapy
10/02/1997WO1997035995A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997WO1997035994A2 Cytochrome p450 transducing retroviral vectors
10/02/1997WO1997035982A2 Monocyte chemotactic protein-5 materials and methods
10/02/1997WO1997035969A2 Peptide ligands of the urokinase receptor
10/02/1997WO1997035885A1 ErbB3 ANTIBODIES
10/02/1997WO1997035873A2 Peptides with antiproliferative properties
10/02/1997WO1997035852A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
10/02/1997WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997WO1997035616A1 Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
10/02/1997WO1997035614A1 The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
10/02/1997WO1997035610A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof
10/02/1997WO1997035609A1 Neovascularization inhibitor containing tissue factor pathway inhibitor
10/02/1997WO1997035581A1 Interleukin-6 production inhibitor
10/02/1997WO1997035571A1 Benzothiophenes, formulations containing same, and methods
10/02/1997WO1997035567A1 Pla2 inhibitors of angiogenesis
10/02/1997WO1997035477A1 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
10/02/1997WO1997023611A3 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/02/1997DE19612463A1 Neues Protein mit differenzierungsinduzierender Aktivität für erythropoetische Zellen Novel protein differenzierungsinduzierender activity for erythropoietic cells
10/02/1997CA2251691A1 Peptides with antiproliferative properties
10/02/1997CA2250576A1 Monocyte chemotactic protein-5 materials and methods
10/02/1997CA2250332A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997CA2250173A1 Cytochrome p450 transducing retroviral vectors
10/02/1997CA2250034A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof
10/02/1997CA2250008A1 Neovascularization inhibitor containing tissue factor pathway inhibitor
10/02/1997CA2249998A1 The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
10/02/1997CA2249354A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/01/1997EP0797988A2 Anti-angiogenic compositions and methods of use
10/01/1997EP0797676A2 Recombinant adenoviral vector and methods of use
10/01/1997EP0797593A2 Improved cyclic crf antagonists
10/01/1997EP0797581A1 Novel protein tyrosine kinase, jak3
10/01/1997EP0797575A1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
10/01/1997EP0797567A1 Novel amino acid derivatives with improved multi-drug resistance activity
10/01/1997EP0797564A1 Lignans, a process for their production and pharmaceutical compositions and uses thereof
10/01/1997EP0797456A1 Anticancer drug with a cytostatic and a contrasting agent
10/01/1997EP0797454A1 Improved adenoviral vectors and producer cells
10/01/1997EP0797447A1 Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
10/01/1997CN1161058A Intracellular isoform of the interleukin-1 receptor antagonist
10/01/1997CN1161039A Novel melatonin agonist 'beta'-carboline derivatives and analogs with a naphthalenic structure, method for their preparation and their use as drugs
10/01/1997CN1036003C A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives
10/01/1997CN1036002C A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives
10/01/1997CN1035996C Stilbene derivatives and carcinostatics
09/1997
09/30/1997US5672757 Antitumor agents
09/30/1997US5672697 Form oligonucleotides stable to nuclease degradation
09/30/1997US5672687 Medical diagnosis; bone marrow transplants
09/30/1997US5672618 Protein kinase C inhibitors
09/30/1997US5672611 Antitumor agents, farnesyl protein transferase enzyme inhibitors
09/30/1997US5672598 Matrix metalloprotease inhibitors
09/30/1997US5672594 Anticarcinogenic,-tumor and -parasitic agents; viricides; fungicides; bactericides; hiv virus
09/30/1997US5672593 Anticancer agents
09/30/1997US5672584 Modified with end groups
09/30/1997US5672583 Carboxy-peptidyl derivatives as antidegenerative active agents
09/30/1997US5672508 Polypeptide comprising cyclin dependent kinase binding motifs from two or more proteins
09/30/1997US5672356 Bioadhesive pharmaceutical composition for the controlled release of active principles
09/29/1997CA2200267A1 Novel sphingolipids and a process thereto
09/27/1997CA2201089A1 Use of .alpha.1 -adrenoreceptor antagonists in the prevention and treatment of cancer
09/25/1997WO1997035024A1 Enzyme combinations for destroying proliferative cells
09/25/1997WO1997035019A1 Protein tyrosine phosphatases of hematopoietic cells
09/25/1997WO1997035014A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF IλB$g(a)
09/25/1997WO1997035012A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy
09/25/1997WO1997035010A1 Chemokine alpha 2
1 ... 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 ... 2211